Harlow, United Kingdom

Chi-Kit Woo


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Slough, GB (2013)
  • Harlow, GB (2014 - 2016)
  • Parma, IT (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Chi-Kit Woo: Innovator in Kinase Inhibitors

Introduction

Chi-Kit Woo is a notable inventor based in Harlow, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 4 patents to his name, Woo's work focuses on compounds that have the potential to treat various inflammatory diseases.

Latest Patents

Chi-Kit Woo's latest patents include innovative compounds featuring [1,2,4]triazolo[4,3-a]pyridine groups. These compounds are identified as p38 MAPK inhibitors, which are useful as anti-inflammatory agents in the treatment of diseases affecting the respiratory tract. His research has led to the disclosure of compounds that hold promise for improving patient outcomes in inflammatory conditions.

Career Highlights

Woo is currently associated with Chiesi Farmaceutici S.p.a., where he continues to advance his research in the pharmaceutical industry. His work has been instrumental in the development of new therapeutic options for patients suffering from respiratory diseases.

Collaborations

Chi-Kit Woo collaborates with talented professionals in his field, including Monique Bodil Van Niel and Harry Finch. These collaborations enhance the innovative potential of his research and contribute to the advancement of pharmaceutical science.

Conclusion

Chi-Kit Woo stands out as a dedicated inventor whose work in kinase inhibitors is paving the way for new treatments in the pharmaceutical industry. His contributions are vital for addressing the challenges posed by inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…